Programme
The meeting will start Monday, 18 March 2024 at 1pm and end on Wednesday 20 March 2024 at noon.
Day |
Start |
Session |
Speaker |
Title |
Monday |
13:00 |
Arrival |
all |
|
13:30 |
Welcome |
Dallmann |
Are we there yet? A fast-paced race towards molecular biomarkers of the clock. |
|
14:00 |
Clinical use cases |
Zee |
Rhythms in ICU |
|
14:30 |
Montagnese |
Chronotyping between questionnaires, wearables and molecular markers |
||
Break |
||||
15:30 |
Anafi |
Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in Luminal A breast cancer |
||
16:00 |
Ruben |
24 h physiological rhythms in hospitalized patients |
||
16:30 |
General Discussion |
|||
Break |
||||
17:30 |
Systems Biology of Clocks |
Ueda |
TBC |
|
19:30 |
Dinner |
|||
Tuesday |
9:00 |
From mathematical concepts to biomarker candidates |
Forger |
Modeling and validating circadian rhythm biomarkers |
9:30 |
Rand |
What clock functionality is accessible from a single transcriptomics sample? |
||
10:00 |
Ananthasubramaniam |
Machine learning approaches to quantifying circadian rhythms in humans |
||
Break |
||||
11:00 |
From concepts to applications 2 |
Dijk |
The promise and pitfalls of biomarker discovery for sleep and circadian processes |
|
11:30 |
Kim |
Digital circadian biomarkers for mood disorders and daytime sleepiness disorder |
||
12:00 |
Kramer |
Transcriptional biomarkers "in the wild" |
||
12:30 |
Lunch |
|||
14:30 |
From concepts to applications 3 |
Hut |
Clocks in the Clinic: Body Clock?? What Body Clock?! |
|
15:00 |
Specht/Mignot |
Studying the circadian clock and sleep homeostasis using proteomic data |
||
15:30 |
Wright |
Assessing central and peripheral circadian timing with omics in humans |
||
Break |
||||
16:30 |
Naef |
Circadian phase inference in human tissues and in single cells |
||
17:00 |
Lightman |
Automated wearable sampling systems in human studies of interstitial fluid biomarkers |
||
Break |
||||
18:00 |
Circadian biomarker must haves |
General Discussion |
|
|
19:30 |
Dinner |
|||
Wednesday |
9:00 |
Consequences for pharmacotherapeutics |
Lehr |
TBC |
9:30 |
Finkenstadt |
TBC |
||
Break |
||||
10:30 |
Discussion |
all |
Concluding discussion and further plan |
|
12:00 |
Thanks and farewell |